Advertisement
Leading cardiologist picks studies with most impact
Aggressive intervention fails to improve outcomes
Unprecedented LDL-C reductions raise hopes for long-term outcome trials
Systems will share clinical, academic and research components
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
A closer look at extended antiplatelet therapy
Further lowering LDL reduces risk in post-ACS patients
20 years, 50 key developments
Veteran surgeon will lead nation’s top cardiac program
From prevention and pacing to stenting and surgery
Rapid acceptance reveals multiple advantages, challenges
Advertisement
Advertisement